AVITA Medical (RCEL) Short-term Investments (2021 - 2025)

AVITA Medical (RCEL) has 5 years of Short-term Investments data on file, last reported at $7.9 million in Q4 2025.

• For the quarter ending Q4 2025, Short-term Investments fell 63.63% year-over-year to $7.9 million; the trailing twelve-month figure through Dec 2025 stood at $7.9 million (down 63.63% YoY), and the FY2025 full-year result was $7.9 million, down 63.63% from the prior year.
• Short-term Investments for Q4 2025 stood at $7.9 million, up from $7.9 million in the prior quarter.
• Across five years, Short-term Investments topped out at $66.9 million in Q4 2023 and bottomed at $3.5 million in Q2 2025.
• The 5-year median for Short-term Investments is $29.7 million (2021), against an average of $33.7 million.
• The widest annual swing landed in 2024, when Short-term Investments surged 178.13%; it then tumbled 90.51% in 2025.
• A 5-year view of Short-term Investments shows it stood at $29.6 million in 2021, then jumped by 106.34% to $61.2 million in 2022, then advanced by 9.42% to $66.9 million in 2023, then tumbled by 67.38% to $21.8 million in 2024, then slumped by 63.63% to $7.9 million in 2025.
• The last three Short-term Investments figures came in at $7.9 million (Q4 2025), $7.9 million (Q3 2025), and $3.5 million (Q2 2025), per Business Quant data.

Peer Comparison